Description

Description

Anplag 90mg is a film-coated tablet manufactured by PharmaEvo, formulated with Ticagrelor as its active ingredient. Each pack contains 20 tablets and is commonly prescribed for patients in the earlier, more intensive phase of antiplatelet treatment, such as immediately following a heart attack or an acute coronary event. Ticagrelor functions by inhibiting platelet aggregation, which helps prevent the formation of blood clots that could otherwise block narrowed or damaged arteries. By keeping the blood flowing more freely, Anplag 90mg plays a key role in reducing the risk of recurrent cardiovascular complications during the critical treatment period following a cardiac event. This medicine is generally prescribed by a cardiologist as part of a comprehensive treatment approach that may include other medications and close medical monitoring.

Ingredients

The active ingredient in Anplag 90mg is Ticagrelor, present at a strength of 90mg per tablet. The tablet also contains standard pharmaceutical excipients such as fillers, binding agents, and a film coating, which support the tablet’s physical stability, appearance, and ease of swallowing. These additional components serve a formulation purpose only and do not contribute any therapeutic effect on their own.

Dosage Form

Anplag 90mg is available as an oral film-coated tablet containing 90mg of Ticagrelor. The pack includes 20 tablets, typically supporting a ten-day supply when taken twice daily, in accordance with the dosing schedule set by the prescribing physician.

Uses

Anplag 90mg is primarily prescribed for patients who have recently experienced an acute coronary syndrome, such as a heart attack or unstable angina, to reduce the risk of further cardiovascular events. It is often used as an initial, higher-strength phase of antiplatelet therapy, sometimes followed later by a lower maintenance dose once the acute risk period has passed, depending on the treating doctor’s assessment. By limiting platelet clumping, this medicine helps protect against clot-related complications in the arteries during a period when patients are considered most vulnerable to recurrent events.

How to Use

Anplag 90mg is typically taken twice daily, roughly twelve hours apart, exactly as prescribed by the treating doctor. The tablet should be swallowed whole with a glass of water and may be taken with or without food. Maintaining a consistent daily schedule is important for ensuring steady antiplatelet effect. This medicine should not be stopped or the dose altered without direct medical guidance, since interrupting treatment during the acute phase after a cardiac event can meaningfully raise the risk of clot-related complications, including stent-related issues in patients who have undergone a cardiac procedure.

Side Effects

The most frequently reported side effect of Ticagrelor is an increased tendency toward bleeding or bruising, which can appear as nosebleeds, bleeding gums, or bleeding that takes longer than usual to stop from small cuts. Some patients experience breathlessness, a fluttering or slow sensation in the heartbeat, dizziness, or headache during treatment. Mild gastrointestinal upset has also been reported. More serious effects, though less common, include major internal bleeding or a notably slowed heart rate, and patients should seek immediate medical attention if they notice symptoms like blood in the urine or stool, coughing or vomiting blood, unexplained bruising, or severe fainting spells.

Pregnancy & Breastfeeding

Anplag 90mg is generally not recommended during pregnancy unless a physician determines that the benefit to the mother clearly outweighs any potential risk, given the limited safety data available and the inherent bleeding risks associated with antiplatelet medicines. Breastfeeding is also typically discouraged while using this medication, as it remains unclear whether or to what degree the active ingredient is transferred into breast milk. Pregnant or breastfeeding individuals should have a detailed discussion with their doctor regarding the risks and alternatives before beginning or continuing this treatment.

Storage Instructions

Anplag tablets should be kept in a cool, dry environment away from direct sunlight and moisture, ideally at controlled room temperature. Tablets should be left in their original blister packaging until the time of use to help preserve their effectiveness. As with all medications, Anplag must be stored securely, out of the reach and sight of children.

FAQs

Why is the 90mg strength used instead of 60mg?
The 90mg strength is generally used during the initial, higher-risk phase following an acute cardiac event, while the 60mg strength may be used later as part of longer-term maintenance therapy, depending on the doctor’s treatment plan.

Is it safe to switch between the 90mg and 60mg strengths on my own?
No, any change in dosage strength should only be made under the direction of a treating physician, as the timing and strength of antiplatelet therapy are carefully determined based on individual risk factors.

What if I notice unusual bruising while on this medicine?
Mild bruising can occur with antiplatelet therapy, but any unusual, excessive, or unexplained bruising or bleeding should be reported to a doctor without delay.

What should I do if I miss a dose?
If a dose is missed, take it as soon as you remember, unless it is nearly time for your next dose, in which case skip the missed dose and continue with your regular schedule rather than doubling the next one.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.